These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33466332)

  • 1. Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.
    Campora M; Francesconi V; Schenone S; Tasso B; Tonelli M
    Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33466332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.
    Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M
    ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fused thiophene as a privileged scaffold: A review on anti-Alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and Aβ aggregation.
    Kassab AE; Gedawy EM; Sayed AS
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):131018. PubMed ID: 38518928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
    Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
    Front Neurosci; 2016; 10():205. PubMed ID: 27252617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation.
    Tonelli M; Catto M; Tasso B; Novelli F; Canu C; Iusco G; Pisani L; Stradis AD; Denora N; Sparatore A; Boido V; Carotti A; Sparatore F
    ChemMedChem; 2015 Jun; 10(6):1040-53. PubMed ID: 25924599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease.
    Tonelli M; Catto M; Sabaté R; Francesconi V; Laurini E; Pricl S; Pisani L; Miniero DV; Liuzzi GM; Gatta E; Relini A; Gavín R; Del Rio JA; Sparatore F; Carotti A
    Eur J Med Chem; 2023 Mar; 250():115169. PubMed ID: 36753881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
    Kumar S; Mahajan A; Ambatwar R; Khatik GL
    Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.
    Dias KS; Viegas C
    Curr Neuropharmacol; 2014 May; 12(3):239-55. PubMed ID: 24851088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Ju Y; Chakravarty H; Tam KY
    ACS Chem Neurosci; 2020 Oct; 11(20):3346-3357. PubMed ID: 33001625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer's Disease by Dual Inhibition of Acetylcholinesterase and Inflammation.
    Liu C; Sang Z; Pan H; Wu Q; Qiu Y; Shi J
    Front Aging Neurosci; 2022; 14():922650. PubMed ID: 35860673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Development of Nitrogen-containing Heterocyclic Anti-alzheimer's Agents.
    Kumar A; Nehra B; Singh D; Kumar D; Chawla PA
    Curr Top Med Chem; 2023; 23(13):1277-1306. PubMed ID: 36278462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
    Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
    Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
    ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A step further towards multitarget drugs for Alzheimer and neuronal vascular diseases: targeting the cholinergic system, amyloid-β aggregation and Ca(2+) dyshomeostasis.
    León R; Marco-Contelles J
    Curr Med Chem; 2011; 18(4):552-76. PubMed ID: 21143111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
    Dey A; Bhattacharya R; Mukherjee A; Pandey DK
    Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.